Added to YB: 2017-07-11
Pitch date: 2017-07-11
AVEO:US [bullish]
AVEO Pharmaceuticals, Inc.
-46.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer.
Market Cap
$521.4M
Pitch Price
$28.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.26
P/E
-17.82
EV/Sales
5.12
Sector
Biotechnology
Category
N/A
Show full summary:
AVEO Pharmaceuticals, Inc. AVEO:US
A summary for this pitch has not been created yet.
Read full article (0 min)